Waterborne disease is emerging as a significant and growing public health threat across both...
NEWS
Breast cancer remains the world’s most-studied disease area in...
Phesi has published its latest annual analysis of global clinical development activity, based on...
Bayer receives Breakthrough Therapy Designation for sevabertinib...
Bayer has received Breakthrough Therapy Designation in the United States and China for sevabertinib...
Alnylam to invest $250 million in enzymatic ligation platform to...
Alnylam Pharmaceuticals has announced a $250 million investment to expand its US manufacturing...